Enteral Feeding Formulas Market By Product Type, By Age Group, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2023-2032

List of Tables

The global enteral feeding formulas market was valued at $6,298.6 million in 2022 and is projected to reach $ 12,706.8 million by 2032, registering a CAGR of 7.4% from 2023 to 2032.

Enteral feeding formulas, also known as tube feeding formulas, are specialized nutritional solutions designed for individuals who cannot consume food orally or have difficulty swallowing. These formulas are primarily used to provide essential nutrients, calories, vitamins, and minerals to patients who rely on tube feeding as their primary source of nutrition. Enteral feeding formulas come in various formulations to meet the specific nutritional needs of different patient populations, such as infants, adults, and elderly individuals. Key factors driving the growth of the enteral feeding formula market are the rise in the geriatric population and the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions.

The escalating growth of the geriatric population has emerged as a significant driving force behind the expansion of the enteral feeding formula market. In recent years, the world has witnessed a remarkable increase in the number of elderly individuals, primarily attributed to advancements in medical care and a rise in life expectancy. According to United Nations World Population Prospects 2022, in 2022, there were 771 million people aged 65 years or over globally and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. As people age, they often encounter various health challenges that can lead to difficulties in maintaining proper nutrition through regular dietary intake. Enteral feeding formulas are designed to provide essential nutrients directly to the digestive system, bypassing any potential obstacles that might hinder nutrient absorption or intake. Given that the elderly population is more susceptible to conditions that can impede their ability to consume a balanced diet, such as dysphagia, neurological disorders, or chronic illnesses, the demand for enteral feeding formulas has surged significantly. Elderly individuals frequently experience medical conditions that can diminish their appetite, impair their ability to swallow or reduce their capacity to absorb nutrients efficiently. As a result, healthcare professionals often turn to enteral feeding formulas to bridge these nutritional gaps and prevent malnutrition, which is a common concern among the elderly. Moreover, the convenience and precision of enteral feeding formulas make them an attractive option for both patients and caregivers. These formulas can be tailored to meet specific dietary requirements and health needs, ensuring that individuals receive the appropriate mix of vitamins, minerals, proteins, and calories. Thus, the rise in the geriatric population has emerged as a major catalyst for the expansion of the enteral feeding formula market.

Furthermore, the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions has also emerged as a major driver for the enteral feeding formula market. Chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, have become increasingly prevalent across various demographics, encompassing both developed and developing nations. This rise can be attributed to factors such as changing lifestyles, aging populations, and environmental influences. According to the American Cancer Society, in 2023, an estimated 12,380 new cases of laryngeal cancer were recorded. In addition, according to MedlinePlus, in 2022, it was estimated that more than half a million Americans are currently affected by this disorder. In many chronic diseases, patients often experience compromised nutritional status due to various reasons, including reduced appetite, difficulty swallowing, impaired digestion, and nutrient malabsorption. This necessitates the utilization of enteral feeding, which involves the delivery of nutrients directly into the gastrointestinal tract through a feeding tube. Enteral feeding formulas play a pivotal role in ensuring that patients receive the required nutrients, vitamins, and minerals in a controlled and easily digestible form. These formulas are specially designed to cater to the specific nutritional needs of patients with chronic diseases, addressing their medical condition while also supporting overall health and well-being. The integration of nutrition as a crucial component of chronic disease management further underscores the importance of enteral feeding formulas in improving patient outcomes and quality of life. Thus, the rise in the prevalence of chronic diseases is expected to drive the growth of the market. However, patient incompatibility and allergies might act as restraints for the enteral feeding formulas.

The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global enteral feeding formulas market are Abbott Laboratories, Nestle, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, DermaRite Industries, LLC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteral feeding formulas market analysis from 2022 to 2032 to identify the prevailing enteral feeding formulas market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the enteral feeding formulas market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global enteral feeding formulas market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Average Selling Price Analysis / Price Point Analysis
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level
SWOT Analysis
Volume Market Size and Forecast

Key Market Segments

By Product Type

Standard Formulas
Disease-specific Formulas
Peptide Based
Immune modulating
Blenderized

By Age Group

Adult
Child

By Application

Cancer
Neurological Disorders
Gastrointestinal Disorders
Malnutrition
Others

By End user

Hospital
Long term Care Facilities
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Abbott Laboratories
Nestle SA
Fresenius SE & Co. KGaA
Meiji Holdings Co. Ltd
Medtrition Inc.
B. Braun Melsungen AG
Hormel Foods Corporation
Nutritional Medicinals, LLC
DermaRite Industries, LLC.
Danone S.A

Product Code: A11424

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Surge in number of preterm births.
  - 3.4.1.2. Rise in geriatric population.
  - 3.4.1.3. Rise in prevalence of chronic disease.
- 3.4.2. Restraints
  - 3.4.2.1. Low patient acceptance
- 3.4.3. Opportunities
  - 3.4.3.1. Opportunities in the emerging markets

CHAPTER 4: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Standard Formulas
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Disease-specific Formulas
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Peptide Based
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Immune modulating
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Blenderized
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country

CHAPTER 5: ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Adult
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Child
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Cancer
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Neurological Disorders
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Gastrointestinal Disorders
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Malnutrition
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
6.6. Others
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country

CHAPTER 7: ENTERAL FEEDING FORMULAS MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Hospital
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Long term Care Facilities
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: ENTERAL FEEDING FORMULAS MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Product Type
- 8.2.3. Market size and forecast, by Age Group
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End user
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by Product Type
  - 8.2.6.1.2. Market size and forecast, by Age Group
  - 8.2.6.1.3. Market size and forecast, by Application
  - 8.2.6.1.4. Market size and forecast, by End user
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by Product Type
  - 8.2.6.2.2. Market size and forecast, by Age Group
  - 8.2.6.2.3. Market size and forecast, by Application
  - 8.2.6.2.4. Market size and forecast, by End user
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by Product Type
  - 8.2.6.3.2. Market size and forecast, by Age Group
  - 8.2.6.3.3. Market size and forecast, by Application
  - 8.2.6.3.4. Market size and forecast, by End user
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Product Type
- 8.3.3. Market size and forecast, by Age Group
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End user
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by Product Type
  - 8.3.6.1.2. Market size and forecast, by Age Group
  - 8.3.6.1.3. Market size and forecast, by Application
  - 8.3.6.1.4. Market size and forecast, by End user
  - 8.3.6.2. France
  - 8.3.6.2.1. Market size and forecast, by Product Type
  - 8.3.6.2.2. Market size and forecast, by Age Group
  - 8.3.6.2.3. Market size and forecast, by Application
  - 8.3.6.2.4. Market size and forecast, by End user
  - 8.3.6.3. UK
  - 8.3.6.3.1. Market size and forecast, by Product Type
  - 8.3.6.3.2. Market size and forecast, by Age Group
  - 8.3.6.3.3. Market size and forecast, by Application
  - 8.3.6.3.4. Market size and forecast, by End user
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Market size and forecast, by Product Type
  - 8.3.6.4.2. Market size and forecast, by Age Group
  - 8.3.6.4.3. Market size and forecast, by Application
  - 8.3.6.4.4. Market size and forecast, by End user
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Market size and forecast, by Product Type
  - 8.3.6.5.2. Market size and forecast, by Age Group
  - 8.3.6.5.3. Market size and forecast, by Application
  - 8.3.6.5.4. Market size and forecast, by End user
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by Product Type
  - 8.3.6.6.2. Market size and forecast, by Age Group
  - 8.3.6.6.3. Market size and forecast, by Application
  - 8.3.6.6.4. Market size and forecast, by End user
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Product Type
- 8.4.3. Market size and forecast, by Age Group
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End user
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Market size and forecast, by Product Type
  - 8.4.6.1.2. Market size and forecast, by Age Group
  - 8.4.6.1.3. Market size and forecast, by Application
  - 8.4.6.1.4. Market size and forecast, by End user
  - 8.4.6.2. China
  - 8.4.6.2.1. Market size and forecast, by Product Type
  - 8.4.6.2.2. Market size and forecast, by Age Group
  - 8.4.6.2.3. Market size and forecast, by Application
  - 8.4.6.2.4. Market size and forecast, by End user
  - 8.4.6.3. Australia
  - 8.4.6.3.1. Market size and forecast, by Product Type
  - 8.4.6.3.2. Market size and forecast, by Age Group
  - 8.4.6.3.3. Market size and forecast, by Application
  - 8.4.6.3.4. Market size and forecast, by End user
  - 8.4.6.4. India
  - 8.4.6.4.1. Market size and forecast, by Product Type
  - 8.4.6.4.2. Market size and forecast, by Age Group
  - 8.4.6.4.3. Market size and forecast, by Application
  - 8.4.6.4.4. Market size and forecast, by End user
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Market size and forecast, by Product Type
  - 8.4.6.5.2. Market size and forecast, by Age Group
  - 8.4.6.5.3. Market size and forecast, by Application
  - 8.4.6.5.4. Market size and forecast, by End user
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by Product Type
  - 8.4.6.6.2. Market size and forecast, by Age Group
  - 8.4.6.6.3. Market size and forecast, by Application
  - 8.4.6.6.4. Market size and forecast, by End user
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Product Type
- 8.5.3. Market size and forecast, by Age Group
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End user
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by Product Type
  - 8.5.6.1.2. Market size and forecast, by Age Group
  - 8.5.6.1.3. Market size and forecast, by Application
  - 8.5.6.1.4. Market size and forecast, by End user
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Market size and forecast, by Product Type
  - 8.5.6.2.2. Market size and forecast, by Age Group
  - 8.5.6.2.3. Market size and forecast, by Application
  - 8.5.6.2.4. Market size and forecast, by End user
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Market size and forecast, by Product Type
  - 8.5.6.3.2. Market size and forecast, by Age Group
  - 8.5.6.3.3. Market size and forecast, by Application
  - 8.5.6.3.4. Market size and forecast, by End user
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Market size and forecast, by Product Type
  - 8.5.6.4.2. Market size and forecast, by Age Group
  - 8.5.6.4.3. Market size and forecast, by Application
  - 8.5.6.4.4. Market size and forecast, by End user

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Abbott Laboratories
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. B. Braun Melsungen AG
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
10.3. Meiji Holdings Co. Ltd
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.3.7. Key strategic moves and developments
10.4. Nestle SA
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
10.5. Hormel Foods Corporation
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
10.6. Fresenius SE & Co. KGaA
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
10.7. Medtrition Inc.
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
10.8. Nutritional Medicinals, LLC
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
10.9. DermaRite Industries, LLC.
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
10.10. Danone S.A
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance